arrow Log In to View Account     |      
HOME
Johns Hopkins Medicine
Hopkins Logo


|
 

Presented by the Johns Hopkins University School of Medicine.

This activity is supported by educational grants and in-kind support from Allergan, Inc, Ipsen Biopharmaceuticals, Inc, Merz North America, Inc, and US WorldMeds, LLC.

Major support comes from Allergan, Inc.

Neurotoxin Injections:
Improving Patient Satisfaction
Zoltan Mari, MD, and Fatta Nahab, MD
OVERVIEW

In conjunction with the complimentary 2015 workshops, this enduring web lecture will provide clinicians, with particular interest in neurotoxins, a unique opportunity to reinforce their knowledge and skills needed for the treatment and management of patients with dystonia and spasticity. This activity will deliver a comprehensive update on recent scholarly data through the presentation and discussion by an expert faculty of the best ways to achieve dystonia and spasticity patient satisfaction through various treatment strategies. The importance of patient satisfaction, patient education, the injection technique employed, and proper patient follow-up are discussed in detail.

GOAL

The purpose of this enduring web lecture activity is to educate residents and fellows in neurology and physical medicine and rehabilitation, community neurologists, physiatrists, and physical and occupational therapists on the science and clinical issues related to the management of patients with dystonia and spasticity. This educational activity also seeks to provide participants with in-depth, evidence-based education including instruction on the safety and efficacy of botulinum toxin injections as well as how to optimize patient treatment satisfaction.

TARGET AUDIENCE

This activity is designed to meet the educational needs of neurology and physical medicine and rehabilitation residents and fellows, as well as community neurologists, physiatrists, physical, and occupational therapists. No prerequisites required.

LEARNING OBJECTIVES

After completing this activity, the participant will demonstrate the ability to:

  • DESCRIBE characteristics efficacy and safety considerations regarding botulinum neurotoxin (BoNT) injection that affect patient satisfaction.
  • IDENTIFY methods to assess and improve patient treatment satisfaction.

The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

ACCREDITATION STATEMENT

The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

The Johns Hopkins University School of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

After reviewing this online activity, participants may receive a certificate by receiving a score of 70% or higher on the CME test and completing an evaluation. A certificate of participation will be available online immediately following successful completion of the activity.

The estimated time to complete this activity: 30 minutes.

Release date: February 19, 2016.   Expiration date: February 19, 2017.

Full Disclosure Policy Affecting CME Activities
As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of the Johns Hopkins University School of Medicine Office of Continuing Medical Education (OCME) to require signed disclosure of the existence of financial relationships with industry from any individual in a position to control the content of a CME activity sponsored by OCME. Members of the Planning Committee are required to disclose all relationships regardless of their relevance to the content of the activity. Faculty are required to disclose only those relationships that are relevant to their specific presentation. The following relationships have been reported for this activity:

Participating Faculty
Zoltan Mari, MD (Chairperson)

Associate Professor of Neurology
Director, Parkinson's and Movement Disorder Center
Director, National Parkinson Foundation Center of Excellence
Director, Deep Brain Stimulation Center
Director, Movement Disorder Fellowship Program
Johns Hopkins University School of Medicine

Fatta Nahab, MD
Associate Professor Department of Neurosciences University of California
San Diego Movement Disorder Center
Director, Movement Disorders
Neuroimaging Program
Director, Functional Imaging of
Neurodegenerative Disorders Laboratory

Participating Faculty Disclosures
Dr Mari receiving grants/research support from AbbVie Inc and Avid; and for serving as a consultant/advisor for Navidea Biopharmaceuticals.

Dr Nahab reports receiving grants/research support from Medtronic Inc; and receiving honoraria from Teva.

No other faculty members have indicated that they have any financial interests or relationships with a commercial entity whose products or services are relevant to the content of their presentation(s).

Planner Disclosures
Dr Mari receiving grants/research support from AbbVie Inc and Avid; and for serving as a consultant/advisor for Navidea Biopharmaceuticals.

No other planners have indicated that they have any financial interests or relationships with a commercial entity.

Note: Grants to investigators at The Johns Hopkins University are negotiated and administered by the institution that receives the grants, typically through the Office of Research Administration. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor, but may receive salary or other support from the institution to support their effort on the project(s).

Off-Label Product Discussion

No speaker has indicated that he/she will reference unlabeled/unapproved uses of drugs or products.

DISCLAIMER

The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

INTERNET CME POLICY

The Office of Continuing Medical Education (CME) at the Johns Hopkins University School of Medicine is committed to protect the privacy of its members and customers. Johns Hopkins University SOM CME maintains its Internet site as an information resource and service for physicians, other health professionals, and the public. Continuing Medical Education at the Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet based activity. Your information will never be given to anyone outside of the Johns Hopkins University School of Medicine’s CME activity. CME collects only the information necessary to provide you with the services that you request.

CONFIDENTIALITY DISCLAIMER FOR CME ACTIVITY PARTICIPANT

I certify that I am participating in this Johns Hopkins University School of Medicine activity for CME-accredited training and/or educational purposes.

I understand that while I am participating in this capacity, I may be exposed to "protected health information," as that term is defined and used in Johns Hopkins policies and in the federal HIPAA privacy regulations (the "Privacy Regulations"). Protected health information is information about a person’s health or treatment that identifies the person. I also understand that while I am participating in this capacity I will be treated as a temporary member of Johns Hopkins for purposes of the Privacy Regulations only.

I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential.

I understand that I may direct to the Johns Hopkins Privacy Officer any questions I have about my obligations under this Confidentiality Pledge or under any of the Hopkins policies and procedures and applicable laws and regulations related to confidentiality. The contact information is: Johns Hopkins Privacy Officer, telephone: 410-735-6509, e-mail: HIPAA@jhmi.edu.

For CME Questions, please contact the CME Office at 410-955-2959 or e-mail cmenet@jhmi.edu. For CME Certificates, please call 410-502-9634.

Johns Hopkins University School of Medicine Office of Continuing Medical Education
Turner 20/720 Rutland Avenue
Baltimore, Maryland 21205-2195

Reviewed & Approved by:
General Counsel, Johns Hopkins Medicine (4/1/03)
(Updated 4/09 and 3/14)

HARDWARE AND SOFTWARE REQUIREMENTS

Pentium 800 processor or greater, Windows 98/NT/200/XP or Mac OS 9/X or later, Microsoft Internet Explorer, Safari, Firefox, Windows Media Player 9.0 or later Flash player, 128 MB of RAM Monitor settings: High color at 800 x 600 pixels, sound card and speakers, Adobe Acrobat Reader.

ACTIVITY

Instructions
The following activity is an enduring web lecture designed to help you gauge your basic knowledge of the topic and then direct you to areas you may need to focus on. It consists of 3 sections: an unaccredited pre-test, the web lecture activity and a CME post-test and evaluation. All 3 sections must be completed to receive CME credit. A certificate of participation will be available online immediately following successful completion of the activity.

Pre-Test

Neurotoxin Injections: Improving Patient Satisfaction

Zoltan Mari, MD, and Fatta Nahab, MD

Post-Test

procced to pretest




Johns Hopkins Advanced Studies in Medicine (ISSN-1558-0334), is published by Galen Publishing, LLC, d/b/a ASiM, PO Box 340, Somerville, NJ 08876. (908) 253-9001. Copyright ©2012 by Galen Publishing. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from the publisher. ASiM is a registered trademark of The Healthcare Media Group, LLC.